Purpose: To determine the prevalence and risk factors for sleep apnea in a keratoconus population.
S leep apnea syndrome is a sleep disorder defined by varying repetitive episodes of apnea for at least 10 seconds and is associated with a reduction in oxygen saturation. 1 In obstructive sleep apnea, the respiratory disturbance is caused by upper airway obstruction resulting from partial to complete airway collapse. 2 Repeated episodes lead to fragmented sleep, hypoxia, excessive daytime sleepiness, fatigue, and automobile accidents. 3, 4 Obstructive sleep apnea can also be life threatening and has been identified as an independent risk factor for systemic hypertension, 5, 6 cardiovascular disease, [7] [8] [9] and stroke. 10, 11 Untreated obstructive sleep apnea is associated with increased risk of all-cause mortality and can lead to premature death. 12, 13 Obstructive sleep apnea has been associated with a variety of ophthalmic conditions including glaucoma, 14, 15 nonarteric ischemic optic neuropathy, 16, 17 floppy eyelid syndrome, [18] [19] [20] [21] [22] [23] [24] retinal vein occlusion, 25 and keratoconus. [26] [27] [28] [29] Floppy eyelid syndrome, a disorder marked by easily everted upper eyelids and papillary conjunctivitis, has also been linked to obstructive sleep apnea and keratoconus. 26, [30] [31] [32] Keratoconus has been linked to obesity, 33 although one study reported that keratoconus was associated with a lower body mass index (BMI). 34 Obesity is also a risk factor for sleep apnea. Identifying the risk factors for obstructive sleep apnea helps to address the public health concern of obstructive sleep apnea because intervention can reduce morbidity and mortality. The purpose of the current study was to characterize the risk of sleep apnea in keratoconus patients compared with a nonkeratoconus contact lens clinic population.
METHODS
Institutional review board approval was obtained before the start of this study. A total of 216 keratoconus patients in the cornea clinic were identified by a retrospective chart review with demographic and medical histories collected at the Department of Ophthalmology, Loyola University Chicago. Keratoconus patients were defined unambiguously by having both clinical and topographical evidence of the disease. We used a modified keratoconus severity score (Table 1) to identify the keratoconus patients. 35 These keratoconus patients were then contacted for a telephone survey, which used the Berlin Questionnaire (BQ), an accepted sleep apnea screening tool proven to effectively classify patients into low-and high-risk categories by calculating BMI and asking questions regarding snoring behavior, daytime somnolence, and history of hypertension. 36 Patients were considered to be at high risk for obstructive sleep apnea if they were at high risk in a minimum of 2 of the following categories: snoring behavior (loudness, frequency, and observed apneas), daytime sleepiness (tired after sleep, fatigue during day, and falling asleep while driving), high blood pressure or BMI greater than or equal to 30 kg/m 2 . 36 A medical history of previously diagnosed obstructive sleep apnea was also recorded. Patients with a positive history of obstructive sleep apnea were included as part of the high-risk group. Informed consent was acquired via telephone before the administration of the survey.
Among the 216 keratoconus patients, 124 were excluded from the study because they could not be reached by telephone or mail or they could not participate in the questionnaire without a proxy. A proxy would not be able to accurately answer the subjective questions regarding the patient's personal feelings about daytime fatigue. This resulted in 92 keratoconus patients who completed the BQ survey.
For the control group, we recruited 92 consecutive new patients to the contact lens service. These patients met the exclusion criteria for keratoconus and were defined as normal according to the criteria listed in Table 1 . Informed consent was given verbally, and the survey was administered during the clinic visit. Responses to the BQ were not linked to clinical outcomes. Subjects found to be at high risk for sleep apnea were referred to the sleep clinic for evaluation. The following patient data were also collected: patient height, weight, age, gender, race, family history of obstructive sleep apnea, and family history of keratoconus.
Statistical Analysis
The patient demographic and clinical characteristics were compared between the keratoconus and control groups using the t test for continuous variables or the x 2 test or the Fisher exact test for categorical variables. Univariate logistic regression analysis was used first to identify the risk factors associated with high risk for sleep apnea in the keratoconus or control group separately, with the risk of sleep apnea (high or low risk) as the outcome. Those variables that were significant in the univariate analyses were subjected to a further multivariate logistic regression. Table 2 shows the demographic and clinical characteristics of the keratoconus and control groups. The 2 groups had similar racial/ethnic distribution and family history of sleep apnea. However, compared with the control group, the keratoconus group had more men (52.2% vs. 32.6%, P = 0.007), higher BMI (29.9 ± 8.56 vs. 27.2 ± 6.03, P = 0.016), higher family history of keratoconus (15.2% vs. 0%, P , 0.001), and higher history of sleep apnea (19.6% vs. 6.5%, P = 0.009) and were more likely to have a high risk of sleep apnea based on BQ/BMI classification (53.3% vs. 27.2%, P , 0.001). There was 1 patient in the keratoconus group who was classified as low risk based on BQ/BMI measures but reported a history of sleep apnea. For further analysis to identify the risk factors associated with a high risk of sleep apnea, this patient was counted in the high-risk group of sleep apnea patients. Table 3 compares the demographic and clinical characteristics between high risk and low risk of sleep apnea in the keratoconus and control groups. In the keratoconus group, only BMI was significantly different between the high-risk Values are given as mean ± SD for continuous variables or N (%) for categorical variables. Items in bold are statistically significant.
RESULTS

Demographic and Clinical Characteristics of the Keratoconus and Control Groups
Risk Factors Associated With High Risk of Sleep Apnea
*P values are from t tests for continuous variables, or x 2 or Fisher exact tests for categorical variables.
†Combining history of sleep apnea and risk of sleep apnea. and low-risk groups. This is not surprising because BMI, together with BQ, was used for high-/low-risk classification.
In the control group, other than BMI, the high-risk group had a significantly lower number of subjects younger than 30 years (0% vs. 22.4%, P = 0.009) and were more likely to have a family history of sleep apnea (32.0% vs. 10.5%, P = 0.013). These factors (age, BMI, and family history of sleep apnea) were also significant in a multivariate analysis in the control group, suggesting 3 variables were the risk factors in the control group.
DISCUSSION
In 1982, Smolin 28 suggested an association between keratoconus and obstructive sleep apnea. Although the connection between the two diseases is unclear, this study confirms Smolin's assertion. Our study finds that those with keratoconus are more likely to have obstructive sleep apnea or be at risk for obstructive sleep apnea by the BQ. The keratoconus group had 18 of 92 (19.6%) patients with a history of obstructive sleep apnea. The control group had only 6 of 92 (6.5%) giving a positive history for obstructive sleep apnea. The keratoconus group had 50 of 92 (54.4%) patients with obstructive sleep apnea by history or high risk by BQ. The control group had 25 of 92 (27.2%) patients with a history or high risk of obstructive sleep apnea.
Obstructive sleep apnea is known to be more prevalent in certain populations. 37 Interestingly, the demographics of keratoconus patients do not match well with the obstructive sleep apnea population. Although obesity has been associated with both keratoconus and obstructive sleep apnea, most other risk factors are not seen in both diseases. Keratoconus patients tend to be younger and healthier than obstructive sleep apnea patients. In our study, patients younger than 30 years in the keratoconus group had a prevalence of high risk for obstructive sleep apnea significantly more commonly than controls (P = 0.009).
By no means does this study show a causal relationship, and the intersection of these disease processes is unclear. Nevertheless, some commonalties are present. Both keratoconus and obstructive sleep apnea have been associated with floppy eyelid syndrome. Indeed, the keratoconic cornea is weak. Corneal hysteresis and corneal resistance factor have been shown to be decreased in keratoconic eyes. [38] [39] [40] Similarly, airway biomechanics are altered in obstructive sleep apnea leading to repetitive collapse of the upper airway. This collapse is thought to be due to a variety of factors including central nervous system control and biomechanical factors including upper airway hysteresis. 41, 42 Hypoxia and reperfusion injury have been suggested as possible players in floppy eyelid syndrome. 20, 32 It is tempting to hypothesize reperfusion oxidation injury as a contributor to the development of keratoconus; however, without further investigation, we cannot determine a causal relationship.
In this study, we used the BQ. The BQ is inherently prone to recall bias as is any questionnaire. The BQ is especially prone to error because it inquires into factors that the subject does not have firsthand knowledge of (ie, their own sleeping habits). Another bias may be induced by the composition of the control group. Despite the fact that the control group had 6.5% of subjects with a history of obstructive sleep apnea-a reasonable level for the general population 43, 44 -the control group had more female patients than male patients, which may have induced bias because sleep disorders are more common in men. 45 Additionally, this patient population may not represent the broader population of keratoconus patients. Because this is an established university-based practice, the patient population may be more diseased than patients in communitybased practices. Those patients with mild disease, or even unrecognized disease, may not be seen in university-based practices. Such a skew in population is a potential selection bias that would be best overcome by expanding this study to multiple centers. Planning for a further study is currently underway. Going forward, the real association of keratoconus and obstructive sleep apnea needs to be elucidated. Because the BQ only stratifies risk and does not actually identify those with obstructive sleep apnea, in the future, the exact risk for obstructive sleep apnea in keratoconus patients should be quantified. This would include screening keratoconus patients with overnight diagnostic sleep studies, such as the polysomnogram, and warrants further investigation.
This study shows that keratoconus patients are at an increased risk for obstructive sleep apnea. Given that obstructive sleep apnea is underdiagnosed 46 and the association shown in this article, ophthalmologists and optometrists should consider screening keratoconus patients for obstructive sleep apnea, if appropriate.
